Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginesatide in CKD patients not on dialysis
NCT00109291Phase 2Terminated
- Sponsor
- Affymax, Inc.
- Start
- Mar 2005
- Primary completion
- Feb 2006
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of peginesatide in anemia of chronic kidney disease (CKD-A), sponsored by Affymax, Inc.. Started Mar 2005; status: terminated.
02
Drugs
peginesatide
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00109291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109291.